# Cannabinoids, Psychosis, Neural Synchrony, and Information Processing > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoids-psychosis-neural-synchrony-and-information-processing/ > **Published:** 2026-07-24T12:15:34-04:00 | **Last Modified / Clinically Audited:** 2026-09-08T20:18:19-04:00 > **Clinical Summary:** How THC disrupts neural synchrony and increases psychosis risk. Clinical screening and risk assessment for cannabis users. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. THCNeurologyMental HealthResearchSafetyAnxietyDosing Why This Matters Clinicians should understand that THC impairs neural synchrony and information processing in ways that may increase [psychosis risk](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/), particularly in vulnerable patients with personal or family histories of psychotic disorders. This mechanistic evidence supports current clinical guidelines recommending against [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in patients with psychosis or [psychosis risk](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) and informs risk stratification discussions with patients considering cannabis for other indications. Knowledge of these neurobiological effects enables clinicians to provide evidence-based counseling about the psychiatric harms of cannabis and to monitor patients who use cannabis despite these risks. Clinical Summary This study investigates the [neurobiological mechanisms](https://cedclinic.com/cannabis-tolerance-behavioral-models/) by which delta-9-tetrahydrocannabinol (THC) affects neural synchrony and information processing, with particular relevance to psychosis risk. Dysregulation of neural synchrony, particularly in gamma-band oscillations, has been implicated in psychotic disorders, and THC appears to disrupt these normal patterns of brain activity and communication between neural networks. These findings provide mechanistic insight into why acute THC use is associated with transient psychotic symptoms and why regular [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), especially in genetically vulnerable individuals, carries elevated risk for psychotic disorders including schizophrenia. Understanding how THC disrupts fundamental neural processing offers a neurobiological framework for counseling patients with personal or family histories of psychosis about cannabis risks. Clinicians should consider this neurophysiological mechanism when discussing [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) with patients and when evaluating new-onset psychotic symptoms in cannabis users, as THC-induced alterations in neural synchrony may explain the dose and frequency dependent relationship between cannabis exposure and psychotic outcomes. Dr. Caplan’s Take “This is an interesting mechanistic study that helps us understand how THC might influence neural processing, but we’re looking at early-stage research that needs replication in larger human cohorts before we can draw firm clinical conclusions about psychosis risk in individual patients.” Clinical Perspective 🧠 While [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and psychotic symptoms have long been associated epidemiologically, this research examining THC’s effects on neural synchrony provides mechanistic insight into how cannabinoids may disrupt information processing in ways that could precipitate or exacerbate psychosis. The challenge for clinicians is that individual vulnerability varies substantially based on genetics, developmental stage, baseline psychiatric risk, and dosing patterns, making it difficult to predict who will experience psychotic sequelae from use. Furthermore, many patients report using cannabis specifically for anxiety or sleep, perceiving benefit despite potential long-term neural risks, creating a tension between symptom relief and [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/). When counseling patients—particularly adolescents and those with personal or family history of psychosis—it remains important to discuss not only the association between cannabis and psychotic disorders but also the emerging mechanistic understanding that THC may disrupt neural communication patterns in ways relevant to psychotic symptomatology. Clin 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabinoids%2C%20Psychosis%2C%20Neural%20Synchrony%2C%20and%20Information%20Processing%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D71309)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D71309)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabinoids%2C%20Psychosis%2C%20Neural%20Synchrony%2C%20and%20Information%20Processing%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D71309)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://trialscreen.org/trials/early-phase-1-cannabinoids-neural-synchrony-information-processing-trial-nct00708994](https://trialscreen.org/trials/early-phase-1-cannabinoids-neural-synchrony-information-processing-trial-nct00708994) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).